title: Protective effect of trimetazidine on amikacin-induced ototoxicity in rats.
abstract: OBJECTIVE
  Aminoglycoside antibiotics are known to have ototoxic effects and may induce sensorineural hearing loss. This study investigated the protective effect of trimetazidine, which has antioxidant and cytoprotective properties, against amikacin ototoxicity.
  
  
  METHODS
  Thirty-two male rats were divided into four groups - amikacin, amikacin + trimetazidine, trimetazidine, and control groups. Trimetazidine, 10 mg/kg per day, was given for 14 days by oral gavage. Amikacin, 600 mg/kg per day, was also given for 14 days, by the intramuscular route. Distortion product otoacoustic emission (DPOAE) and auditory brainstem response (ABR) tests were applied to the rats for hearing assessment. At the termination of the study, the biochemical parameters were calculated to evaluate the oxidative status.
  
  
  RESULTS
  The DPOAE values of the amikacin group were significantly lower on the 7th and 14th days than those of the trimetazidine + amikacin group and there was an increase in the ABR thresholds. The ABR thresholds for the amikacin group on the 7th and 14th days were significantly higher than the levels on the first day of the study, while there was no significant increase in those values in the trimetazidine + amikacin group. The total oxidant status (TOS) and oxidant status index (OSI) values of the amikacin group were significantly higher than those of the trimetazidine + amikacin group. The total antioxidant status (TAS) values of the amikacin group were lower than those of the trimetazidine + amikacin group.
  
  
  CONCLUSIONS
  The audiologic tests and biochemical parameters investigated in this study both point to the protective effect of trimetazidine against amikacin-induced ototoxicity.
authors.affiliation: Bezmialem Vakif University, Department of Otorhinolaryngology, Fatih, Istanbul, Turkey.
authors.forename: Fadlullah
authors.initials: F
authors.lastname: Aksoy
authors.affiliation: Bezmialem Vakif University, Department of Otorhinolaryngology, Fatih, Istanbul, Turkey. Electronic address: dr.remzidogan@gmail.com.
authors.forename: Remzi
authors.initials: R
authors.lastname: Dogan
authors.affiliation: Bezmialem Vakif University, Department of Otorhinolaryngology, Fatih, Istanbul, Turkey.
authors.forename: Orhan
authors.initials: O
authors.lastname: Ozturan
authors.affiliation: Bezmialem Vakif University, Department of Otorhinolaryngology, Fatih, Istanbul, Turkey.
authors.forename: Sabri Baki
authors.initials: SB
authors.lastname: Eren
authors.affiliation: Bezmialem Vakif University, Department of Otorhinolaryngology, Fatih, Istanbul, Turkey.
authors.forename: Bayram
authors.initials: B
authors.lastname: Veyseller
authors.affiliation: Bezmialem Vakif University, Faculty of Health Sciences, Department of Audiology, Fatih, Istanbul, Turkey.
authors.forename: Alev
authors.initials: A
authors.lastname: Pektas
authors.affiliation: Bezmialem Vakif University, Research Center, Fatih, Istanbul, Turkey.
authors.forename: Önder
authors.initials: Ö
authors.lastname: Hüseyinbas
mesh_terms: D000583:Amikacin / Q000494:pharmacology / Q000633:toxicity*; D000818:Animals; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004432:Ear, Middle / Q000187:drug effects; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects*; D005260:Female; D034381:Hearing Loss / Q000139:chemically induced* / Q000517:prevention & control*; D008297:Male; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values; D014292:Trimetazidine / Q000494:pharmacology*
chemical_list: D000583:Amikacin; D014292:Trimetazidine
keywords: ABR; Amikacin; DPOAE; Oxidative status; Trimetazidine